Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Arrhythmias

  Free Subscription


Articles published in J Am Coll Cardiol

Retrieve available abstracts of 388 articles:
HTML format



Single Articles


    July 2021
  1. THOMAS KL, Al-Khalidi HR, Silverstein AP, Monahan KH, et al
    Ablation Versus Drug Therapy for Atrial Fibrillation in Racial and Ethnic Minorities.
    J Am Coll Cardiol. 2021;78:126-138.
    PubMed     Abstract available


    June 2021
  2. GRANGER CB, Pokorney SD
    Preventing and Managing Bleeding With Anticoagulation for Atrial Fibrillation.
    J Am Coll Cardiol. 2021;77:3002-3004.
    PubMed    


  3. DI MARCO A, Brown PF, Bradley J, Nucifora G, et al
    Improved Risk Stratification for Ventricular Arrhythmias and Sudden Death in Patients With Nonischemic Dilated Cardiomyopathy.
    J Am Coll Cardiol. 2021;77:2890-2905.
    PubMed     Abstract available


  4. LURIE A, Wang J, Hinnegan KJ, McIntyre WF, et al
    Prevalence of Left Atrial Thrombus in Anticoagulated Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2021;77:2875-2886.
    PubMed     Abstract available


  5. CHEN YC, Voskoboinik A, Gerche A, Marwick TH, et al
    Prevention of Pathological Atrial Remodeling and Atrial Fibrillation: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:2846-2864.
    PubMed     Abstract available


    May 2021
  6. AKTAS MK, Younis A, Zareba W, Kutyifa V, et al
    Survival After Implantable Cardioverter-Defibrillator Shocks.
    J Am Coll Cardiol. 2021;77:2453-2462.
    PubMed     Abstract available


  7. NACCARELLI GV, Filippone EJ, Foy A
    Do Mineralcorticoid Receptor Antagonists Suppress Atrial Fibrillation/Flutter?
    J Am Coll Cardiol. 2021 May 4. pii: S0735-1097(21)04967.
    PubMed    


  8. FILIPPATOS G, Bakris GL, Pitt B, Agarwal R, et al
    Finerenone Reduces Onset of Atrial Fibrillation in Patients with Chronic Kidney Disease and Type 2 Diabetes.
    J Am Coll Cardiol. 2021 May 4. pii: S0735-1097(21)04966.
    PubMed     Abstract available


    April 2021
  9. SELVARAJ S, Claggett B, Minamisawa M, Windham BG, et al
    Atrial Fibrillation and Ischemic Stroke with the Amyloidogenic V122I Transthyretin Variant among Black Americans.
    J Am Coll Cardiol. 2021 Apr 19. pii: S0735-1097(21)04808.
    PubMed    


    March 2021
  10. ROMERO J, Velasco A, Pisani CF, Alviz I, et al
    Advanced Therapies for Ventricular Arrhythmias in Patients With Chagasic Cardiomyopathy: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:1225-1242.
    PubMed     Abstract available


  11. HALPERIN JL, Rashed ER
    Low-Dose Anticoagulation for Atrial Fibrillation: When Is a Floor a Trap Door?
    J Am Coll Cardiol. 2021;77:1208-1210.
    PubMed    


  12. STEFFEL J, Ruff CT, Yin O, Braunwald E, et al
    Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2021;77:1197-1207.
    PubMed     Abstract available


    February 2021
  13. ZEITLER EP, Piccini JP
    Pre-Diabetes and Stroke in Patients With Atrial Fibrillation: When Risk Begets Risk.
    J Am Coll Cardiol. 2021;77:885-887.
    PubMed    


  14. KEZERLE L, Tsadok MA, Akriv A, Senderey AB, et al
    Pre-Diabetes Increases Stroke Risk in Patients With Nonvalvular Atrial Fibrillation.
    J Am Coll Cardiol. 2021;77:875-884.
    PubMed     Abstract available


    January 2021
  15. ALEXANDER JH
    Preventing Atrial Fibrillation After Cardiac Surgery: What Matters Most.
    J Am Coll Cardiol. 2021;77:68-70.
    PubMed    


  16. WANG H, Zhang Y, Xin F, Jiang H, et al
    Calcium-Induced Autonomic Denervation in Patients With Post-Operative Atrial Fibrillation.
    J Am Coll Cardiol. 2021;77:57-67.
    PubMed     Abstract available


  17. ARAI AE, Bradley AJ, Sirajuddin A
    Risk Stratification for Sudden Death and Arrhythmias: A Role for Gadolinium-Enhanced CMR.
    J Am Coll Cardiol. 2021;77:42-44.
    PubMed    


  18. ZEGARD A, Okafor O, de Bono J, Kalla M, et al
    Myocardial Fibrosis as a Predictor of Sudden Death in Patients With Coronary Artery Disease.
    J Am Coll Cardiol. 2021;77:29-41.
    PubMed     Abstract available


    December 2020
  19. REDDY VY, Neuzil P, Anic A
    Reply: Pulsed Field Ablation for Persistent Atrial Fibrillation: Do Electrophysiological Endpoints Predict Clinical Benefit?
    J Am Coll Cardiol. 2020;76:3065-3066.
    PubMed    


  20. FUTYMA P, Kulakowski P
    Pulsed Field Ablation for Persistent Atrial Fibrillation: Do Electrophysiological Endpoints Predict Clinical Benefit?
    J Am Coll Cardiol. 2020;76:3064-3065.
    PubMed    


  21. EL-ESHMAWI A, Pandis D, Miller MA, Boateng P, et al
    Surgical Cryoablation of Papillary Muscle PVCs During Mitral Valve Surgery: Therapeutic Consideration for Malignant MVP.
    J Am Coll Cardiol. 2020;76:3061-3062.
    PubMed    


  22. FAXEN J, Jernberg T, Hollenberg J, Gadler F, et al
    Incidence and Predictors of Out-of-Hospital Cardiac Arrest Within 90 Days After Myocardial Infarction.
    J Am Coll Cardiol. 2020;76:2926-2936.
    PubMed     Abstract available


  23. MARWICK TH
    Echocardiography in Long QT Syndrome: The Mechanical Face of an Electrical Disease.
    J Am Coll Cardiol. 2020;76:2844-2846.
    PubMed    


  24. SUGRUE A, van Zyl M, Enger N, Mancl K, et al
    Echocardiography-Guided Risk Stratification for Long QT Syndrome.
    J Am Coll Cardiol. 2020;76:2834-2843.
    PubMed     Abstract available


  25. BHAGIRATH VC, Chan N, Hirsh J, Ginsberg J, et al
    Plasma Apixaban Levels in Patients Treated Off Label With the Lower Dose.
    J Am Coll Cardiol. 2020;76:2906-2907.
    PubMed    


  26. TURAGAM MK, Osmancik P, Neuzil P, Dukkipati SR, et al
    Left Atrial Appendage Closure Versus Oral Anticoagulants in Atrial Fibrillation: A Meta-Analysis of Randomized Trials.
    J Am Coll Cardiol. 2020;76:2795-2797.
    PubMed    


  27. HEIDENREICH PA, Estes NAM 3rd, Fonarow GC, Jurgens CY, et al
    2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
    J Am Coll Cardiol. 2020 Dec 1. pii: S0735-1097(20)36400.
    PubMed    


    November 2020
  28. KUMBHANI DJ, Cannon CP, Beavers CJ, Bhatt DL, et al
    2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Report
    J Am Coll Cardiol. 2020 Nov 26. pii: S0735-1097(20)36615.
    PubMed    


  29. NATTEL S, Guichard JB
    Reply: Could Different Thresholds for Tachycardic-Induced Atrial Myopathy Reflect Different Rates Between Atrial Fibrillation and Flutter?
    J Am Coll Cardiol. 2020;76:2179-2180.
    PubMed    


  30. REIFFEL JA
    Could Different Thresholds for Tachycardic-Induced Atrial Myopathy Reflect Different Rates Between Atrial Fibrillation and Flutter?
    J Am Coll Cardiol. 2020;76:2179.
    PubMed    


    October 2020
  31. KOSUGI S, Shinouchi K, Ueda Y, Abe H, et al
    Clinical and Angiographic Features of Patients With Out-of-Hospital Cardiac Arrest and Acute Myocardial Infarction.
    J Am Coll Cardiol. 2020;76:1934-1943.
    PubMed     Abstract available


  32. CHAN YH, Chao TF, Lee HF, Yeh YH, et al
    Impacts of Different Renal Function Estimation Formulas on Dosing of DOACs and Clinical Outcomes.
    J Am Coll Cardiol. 2020;76:1808-1810.
    PubMed    


  33. SHIVKUMAR K, Do DH
    Catheter Ablation of Ventricular Tachycardia: First, Treat the Underlying Disease.
    J Am Coll Cardiol. 2020;76:1657-1659.
    PubMed    


  34. PERETTO G, Sala S, Basso C, Rizzo S, et al
    Inflammation as a Predictor of Recurrent Ventricular Tachycardia After Ablation in Patients With Myocarditis.
    J Am Coll Cardiol. 2020;76:1644-1656.
    PubMed     Abstract available


    September 2020
  35. CAMM AJ, Cools F, Virdone S, Bassand JP, et al
    Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants.
    J Am Coll Cardiol. 2020;76:1425-1436.
    PubMed     Abstract available


  36. NACCARELLI GV
    Direct Oral Anticoagulant Dosing: Truth or Consequences.
    J Am Coll Cardiol. 2020;76:1437-1439.
    PubMed    


  37. VARMA N, Marrouche NF, Aguinaga L, Albert CM, et al
    HRS/EHRA/APHRS/LAHRS/ACC/AHA Worldwide Practice Update for Telehealth and Arrhythmia Monitoring During and After a Pandemic.
    J Am Coll Cardiol. 2020;76:1363-1374.
    PubMed    


  38. NALLIAH CJ, Bell JR, Raaijmakers AJA, Waddell HM, et al
    Epicardial Adipose Tissue Accumulation Confers Atrial Conduction Abnormality.
    J Am Coll Cardiol. 2020;76:1197-1211.
    PubMed     Abstract available


  39. TOMLINSON DR, Mandrola J
    Pulsed Field Ablation for Persistent Atrial Fibrillation (PersAFOne): Hope or Hype?
    J Am Coll Cardiol. 2020;76:1081-1083.
    PubMed    


  40. REDDY VY, Anic A, Koruth J, Petru J, et al
    Pulsed Field Ablation in Patients With Persistent Atrial Fibrillation.
    J Am Coll Cardiol. 2020;76:1068-1080.
    PubMed     Abstract available


  41. KOSMALA W
    Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation: How to Fight Allied Enemies.
    J Am Coll Cardiol. 2020;76:1065-1067.
    PubMed    


  42. REDDY YNV, Obokata M, Verbrugge FH, Lin G, et al
    Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation.
    J Am Coll Cardiol. 2020;76:1051-1064.
    PubMed     Abstract available


    August 2020
  43. AMELOOT K, Jakkula P, Hastbacka J, Reinikainen M, et al
    Optimum Blood Pressure in Patients With Shock After Acute Myocardial Infarction and Cardiac Arrest.
    J Am Coll Cardiol. 2020;76:812-824.
    PubMed     Abstract available


  44. YAFASOVA A, Fosbol EL, Schou M, Gustafsson F, et al
    Long-Term Adverse Cardiac Outcomes in Patients With Sarcoidosis.
    J Am Coll Cardiol. 2020;76:767-777.
    PubMed     Abstract available


  45. GARBI M, Garweg C
    Arrhythmia in Mitral Valve Prolapse: All Roads Lead to Rome.
    J Am Coll Cardiol. 2020;76:650-652.
    PubMed    


  46. ESSAYAGH B, Sabbag A, Antoine C, Benfari G, et al
    Presentation and Outcome of Arrhythmic Mitral Valve Prolapse.
    J Am Coll Cardiol. 2020;76:637-649.
    PubMed     Abstract available


  47. BRABRAND M, Jensen HK, Ekelund U, Forberg JL, et al
    QTc Interval Prolongation Is a Proxy for Increased Short-Term Mortality.
    J Am Coll Cardiol. 2020;76:630-631.
    PubMed    


  48. TOMASELLI GF, Mahaffey KW, Cuker A, Dobesh PP, et al
    2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee.
    J Am Coll Cardiol. 2020;76:594-622.
    PubMed    


    July 2020
  49. NAZARI MA, Rosenblum JS, Haigney MC, Rosing DR, et al
    Pathophysiology and Acute Management of Tachyarrhythmias in Pheochromocytoma: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;76:451-464.
    PubMed     Abstract available


  50. POOLE JE, Olshansky B, Mark DB, Anderson J, et al
    Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT.
    J Am Coll Cardiol. 2020;76:405-415.
    PubMed     Abstract available


  51. CALKINS H
    Important Differences Exist Between Atrial Fibrillation and Atrial Flutter in Atrial Remodeling.
    J Am Coll Cardiol. 2020;76:389-390.
    PubMed    


  52. GUICHARD JB, Naud P, Xiong F, Qi X, et al
    Comparison of Atrial Remodeling Caused by Sustained Atrial Flutter Versus Atrial Fibrillation.
    J Am Coll Cardiol. 2020;76:374-388.
    PubMed     Abstract available


  53. RWEBEMBERA J, Jeilan M, Ajijola OA, Talle M, et al
    Cardiac Pacing Training in Africa: Endorsed by the Africa Heart Rhythm Association (AFHRA): JACC International.
    J Am Coll Cardiol. 2020;76:465-472.
    PubMed     Abstract available


  54. POKORNEY SD, Black-Maier E, Piccini JP
    Reply: Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal Disease.
    J Am Coll Cardiol. 2020;76:351-352.
    PubMed    


  55. ILYAS I, Doshi R
    The Difficult Balance of Oral Anticoagulation in Patients With End-Stage Renal Disease.
    J Am Coll Cardiol. 2020;76:350-351.
    PubMed    


  56. BURLACU A, Covic A
    The Devil Is in the Details When Considering the OAC Efficacy-Safety Equation in Dialysis Patients.
    J Am Coll Cardiol. 2020;76:349-350.
    PubMed    


  57. STRASBURGER JF, Wacker-Gussmann A
    Congenital Heart Block in Subsequent Pregnancies of SSA/Ro-Positive Mothers: Cutting Recurrence in Half.
    J Am Coll Cardiol. 2020;76:303-305.
    PubMed    


  58. IZMIRLY P, Kim M, Friedman DM, Costedoat-Chalumeau N, et al
    Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers.
    J Am Coll Cardiol. 2020;76:292-302.
    PubMed     Abstract available


  59. JAAKKOLA S, Nuotio I, Hartikainen JEK, Airaksinen KEJ, et al
    Early Cardioversion for Acute Atrial Fibrillation in Low Stroke Risk Patients Is Safe Without Anticoagulation.
    J Am Coll Cardiol. 2020;76:226-227.
    PubMed    


  60. PERETTO G, Sala S, Della Bella P, Basso C, et al
    Reply: Genetic Basis for Acute Myocarditis Presenting With Ventricular Arrhythmias?
    J Am Coll Cardiol. 2020;76:126-128.
    PubMed    


  61. KALRA R, Nijjar PS
    Genetic Basis for Acute Myocarditis Presenting With Ventricular Arrhythmias?
    J Am Coll Cardiol. 2020;76:126.
    PubMed    


    June 2020
  62. OSMANCIK P, Herman D, Neuzil P, Hala P, et al
    Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2020;75:3122-3135.
    PubMed     Abstract available


  63. POOLE JE, Bahnson TD, Monahan KH, Johnson G, et al
    Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial.
    J Am Coll Cardiol. 2020;75:3105-3118.
    PubMed     Abstract available


  64. GOLLOB MH
    COVID-19, Clinical Trials, and QT-Prolonging Prophylactic Therapy in Healthy Subjects: First, Do No Harm.
    J Am Coll Cardiol. 2020;75:3184-3186.
    PubMed    


  65. PRICE MJ, Saw J
    Transcatheter Left Atrial Appendage Occlusion in the DOAC Era.
    J Am Coll Cardiol. 2020;75:3136-3139.
    PubMed    


  66. MARCHLINSKI FE, Walsh K, Guandalini GS
    Reporting AF Recurrence After Catheter Ablation: The Burden Is on Us to Get it Right.
    J Am Coll Cardiol. 2020;75:3119-3121.
    PubMed    


  67. CHANG D, Saleh M, Gabriels J, Ismail H, et al
    Inpatient Use of Ambulatory Telemetry Monitors for COVID-19 Patients Treated With Hydroxychloroquine and/or Azithromycin.
    J Am Coll Cardiol. 2020;75:2992-2993.
    PubMed    


  68. BLUEMKE DA, James CA, Te Riele ASJM
    Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy: Not a One-Size-Fits-All Strategy.
    J Am Coll Cardiol. 2020;75:2766-2768.
    PubMed    


  69. AQUARO GD, De Luca A, Cappelletto C, Raimondi F, et al
    Prognostic Value of Magnetic Resonance Phenotype in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    J Am Coll Cardiol. 2020;75:2753-2765.
    PubMed     Abstract available


  70. KHALID U, Marzec LN, Mantini N, Manson SM, et al
    Treatment of AF in American Indians and Alaska Natives: Insights From the NCDR PINNACLE-AF Registry.
    J Am Coll Cardiol. 2020;75:2749-2750.
    PubMed    


    May 2020
  71. RODEN DM, Harrington RA, Poppas A, Russo AM, et al
    Considerations for Drug Interactions on QTc Interval in Exploratory COVID-19 Treatment.
    J Am Coll Cardiol. 2020;75:2623-2624.
    PubMed    


  72. BOUTJDIR M, Lazzerini PE
    A Novel Peptide/Antibody-Based Antiarrhythmic Approach to Long QT Syndrome and Beyond.
    J Am Coll Cardiol. 2020;75:2153-2155.
    PubMed    


  73. MAGUY A, Kucera JP, Wepfer JP, Forest V, et al
    KCNQ1 Antibodies for Immunotherapy of Long QT Syndrome Type 2.
    J Am Coll Cardiol. 2020;75:2140-2152.
    PubMed     Abstract available


    April 2020
  74. ACKERMAN MJ, Giudicessi JR
    Time to Redefine the Natural History and Clinical Management of Type 1 Andersen-Tawil Syndrome?
    J Am Coll Cardiol. 2020;75:1785-1787.
    PubMed    


  75. MAZZANTI A, Guz D, Trancuccio A, Pagan E, et al
    Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1.
    J Am Coll Cardiol. 2020;75:1772-1784.
    PubMed     Abstract available


  76. GALLI M, Andreotti F, D'Amario D, Porto I, et al
    Stent Thrombosis With Dual Antithrombotic Therapy in Atrial Fibrillation-ACS/PCI Trials.
    J Am Coll Cardiol. 2020;75:1727-1728.
    PubMed    


  77. MADIAS C, Parzynski CS, Burrows A, Minges KE, et al
    Utilization Effects of the Affordable Care Act on Implantable Cardioverter-Defibrillator Therapy.
    J Am Coll Cardiol. 2020;75:1714-1717.
    PubMed    


  78. CHUNG MK, Refaat M, Shen WK, Kutyifa V, et al
    Atrial Fibrillation: JACC Council Perspectives.
    J Am Coll Cardiol. 2020;75:1689-1713.
    PubMed     Abstract available


  79. RUFF CT
    The Promise of Mobile Health in Managing Atrial Fibrillation.
    J Am Coll Cardiol. 2020;75:1535-1537.
    PubMed    


  80. GUO Y, Lane DA, Wang L, Zhang H, et al
    Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2020;75:1523-1534.
    PubMed     Abstract available


  81. LAKKIREDDY DR, Turagam MK
    NCDR Left Atrial Appendage Occlusion Registry: The "Watch" Man Has Arrived.
    J Am Coll Cardiol. 2020;75:1519-1522.
    PubMed    


  82. SANA F, Isselbacher EM, Singh JP, Heist EK, et al
    Wearable Devices for Ambulatory Cardiac Monitoring: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2020;75:1582-1592.
    PubMed     Abstract available


  83. FREEMAN JV, Varosy P, Price MJ, Slotwiner D, et al
    The NCDR Left Atrial Appendage Occlusion Registry.
    J Am Coll Cardiol. 2020;75:1503-1518.
    PubMed     Abstract available


    March 2020
  84. STEVENSON LW, Naftilan AJ
    Changing the Stage Directions for Heart Failure?
    J Am Coll Cardiol. 2020;75:1439-1442.
    PubMed    


  85. GUO Y, Liu T, Chen Y, Lip GYH, et al
    Reply: Observations From the Huawei Heart Study Using Photoplethysmography-Based Smart Devices for Atrial Fibrillation Screening.
    J Am Coll Cardiol. 2020;75:1366-1367.
    PubMed    


  86. EERIKAINEN LM, Bonomi AG, Dekker LRC, Aarts RM, et al
    Atrial Fibrillation Episodes Detected Using Photoplethysmography: Do We Know Which Are True?
    J Am Coll Cardiol. 2020;75:1365.
    PubMed    


  87. ANANTHAN K
    The Efficacy and Feasibility of Atrial Fibrillation Screening Using Photoplethysmography-Based Smart Devices.
    J Am Coll Cardiol. 2020;75:1365-1366.
    PubMed    


  88. SEPEHRI SHAMLOO A, Bollmann A, Dagres N, Arya A, et al
    Smart Watch Devices for Atrial Fibrillation Screening: It Has to Start Somewhere.
    J Am Coll Cardiol. 2020;75:1364-1365.
    PubMed    


  89. PONG T, Cyr K, Niesen J, Aparicio-Valenzuela J, et al
    Screening and Prophylactic Amiodarone Reduces Post-Operative Atrial Fibrillation in At-Risk Patients.
    J Am Coll Cardiol. 2020;75:1361-1363.
    PubMed    


  90. POKORNEY SD, Black-Maier E, Hellkamp AS, Friedman DJ, et al
    Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal Disease.
    J Am Coll Cardiol. 2020;75:1299-1308.
    PubMed     Abstract available


  91. OLESEN JB, Bonde AN
    When Oral Anticoagulation Becomes Difficult.
    J Am Coll Cardiol. 2020;75:1309-1310.
    PubMed    


  92. BENSON L, Horlick E, Osten M
    Percutaneous Repair of the Sinus Venosus Atrial Defect: Usus Est Magister Optimus.
    J Am Coll Cardiol. 2020;75:1279-1280.
    PubMed    


  93. DRIGGIN E, Madhavan MV, Bikdeli B, Chuich T, et al
    Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic.
    J Am Coll Cardiol. 2020 Mar 18. pii: S0735-1097(20)34637.
    PubMed     Abstract available


  94. CHENG EP, Yeo I, Kim LK, Lerman BB, et al
    Reply: Early Mortality Following Catheter Ablation of Atrial Fibrillation.
    J Am Coll Cardiol. 2020;75:1245-1247.
    PubMed    


  95. REN JF, Chen S, Callans DJ, Jiang C, et al
    Role of Intracardiac Echocardiography for Catheter Ablation of Atrial Fibrillation: Reduction of Complications and Mortality.
    J Am Coll Cardiol. 2020;75:1244-1245.
    PubMed    


  96. BOLLMANN A, Konig S, Basedow F, Hindricks G, et al
    Early Mortality After Catheter Ablation of Atrial Fibrillation.
    J Am Coll Cardiol. 2020;75:1243-1244.
    PubMed    


  97. REYNOLDS MR, Kramer DB, Yeh RW, Cohen DJ, et al
    AF Ablation Outcomes: Real World or Fun House Mirror?
    J Am Coll Cardiol. 2020;75:1243.
    PubMed    


  98. KHO C
    Can Patient Pluripotent Stem Cell-Derived Cardiomyocytes Provide Useful Modeling on Arrhythmias of DMD Cardiomyopathy?
    J Am Coll Cardiol. 2020;75:1175-1177.
    PubMed    


  99. ZEITOUNI M, Giczewska A, Lopes RD, Wojdyla DM, et al
    Clinical and Pharmacological Effects of Apixaban Dose Adjustment in the ARISTOTLE Trial.
    J Am Coll Cardiol. 2020;75:1145-1155.
    PubMed     Abstract available


  100. COOPER LT JR
    Ventricular Arrhythmias and Sudden Cardiac Death in Lymphocytic Myocarditis.
    J Am Coll Cardiol. 2020;75:1058-1060.
    PubMed    


  101. PERETTO G, Sala S, Rizzo S, Palmisano A, et al
    Ventricular Arrhythmias in Myocarditis: Characterization and Relationships With Myocardial Inflammation.
    J Am Coll Cardiol. 2020;75:1046-1057.
    PubMed     Abstract available


  102. BINDING C, Olesen JB, Bonde AN
    Reply: Anticoagulant Therapy and Hip Fracture Risk: A Possible Involvement of Physical Activity.
    J Am Coll Cardiol. 2020;75:987-988.
    PubMed    


  103. SUGIYAMA T
    Anticoagulant Therapy and Hip Fracture Risk: A Possible Involvement of Physical Activity.
    J Am Coll Cardiol. 2020;75:987.
    PubMed    


  104. STEVENSON WG, Richardson TD, Kanagasundram A
    Ventricular Tachycardia in 3 Dimensions.
    J Am Coll Cardiol. 2020;75:898-900.
    PubMed    


  105. TUNG R, Raiman M, Liao H, Zhan X, et al
    Simultaneous Endocardial and Epicardial Delineation of 3D Reentrant Ventricular Tachycardia.
    J Am Coll Cardiol. 2020;75:884-897.
    PubMed     Abstract available


    February 2020
  106. SIONTIS KC, Checkole S, Yao X, Gersh BJ, et al
    Do Observational Studies Agree With Randomized Trials?: Evaluation of Oral Anticoagulants in Atrial Fibrillation.
    J Am Coll Cardiol. 2020;75:562-563.
    PubMed    


  107. VIJAYARAMAN P, Nayak HM, Ellenbogen KA
    Left Ventricular Septal Versus Left Bundle Branch Pacing: A New Beginning in Cardiac Resynchronization Therapy?
    J Am Coll Cardiol. 2020;75:360-362.
    PubMed    


  108. SALDEN FCWM, Luermans JGLM, Westra SW, Weijs B, et al
    Short-Term Hemodynamic and Electrophysiological Effects of Cardiac Resynchronization by Left Ventricular Septal Pacing.
    J Am Coll Cardiol. 2020;75:347-359.
    PubMed     Abstract available


    January 2020
  109. WALD R, Dorian P, Harel Z
    Benefits and Risks of Anticoagulation in Dialysis Patients With Nonvalvular Atrial Fibrillation: Navigating Through Darkness.
    J Am Coll Cardiol. 2020;75:286-288.
    PubMed    


  110. KUNO T, Takagi H, Ando T, Sugiyama T, et al
    Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Hemodialysis.
    J Am Coll Cardiol. 2020;75:273-285.
    PubMed     Abstract available


  111. STEG PG, Ducrocq G, Bhatt DL, Hohnloser SH, et al
    Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post PCI in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2020;75:238-240.
    PubMed    


  112. BISBAL F, Baranchuk A, Braunwald E, Bayes de Luna A, et al
    Atrial Failure as a Clinical Entity: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;75:222-232.
    PubMed     Abstract available


  113. COHEN A
    Is Persistent Isolation of the LAA Necessary to Achieve Higher Success Rates in Atrial Fibrillation?
    J Am Coll Cardiol. 2020;75:128-129.
    PubMed    


  114. REDDY VY
    Reply: Common Carotid Artery Filter to Prevent Stroke in Atrial Fibrillation: A Neurologist's and Neuroradiologist's Perspective.
    J Am Coll Cardiol. 2020;75:127-128.
    PubMed    


  115. PAPANAGIOTOU P, Tsivgoulis G
    Common Carotid Artery Filter to Prevent Stroke in Atrial Fibrillation: A Neurologist's and Neuroradiologist's Perspective.
    J Am Coll Cardiol. 2020;75:126-127.
    PubMed    


  116. PAGANO G, Cannavo A, Rengo G
    Is the Hitman in Cardiac Death Hidden in the Sympathetic Nervous System Remodeling?
    J Am Coll Cardiol. 2020;75:14-16.
    PubMed    


  117. DI BIASE L, Mohanty S, Romero J, Della Rocca DG, et al
    Reply: LAA Electrical Isolation: A Tool to Achieve Superior Ablation Success Under Protection of Optimal Anticoagulation.
    J Am Coll Cardiol. 2020;75:130-131.
    PubMed    


  118. ADELINO R, Bazan V, Villuendas R, Bisbal F, et al
    Left Atrial Appendage Isolation and Preserved Function: Is it Really Isolated?
    J Am Coll Cardiol. 2020;75:129-130.
    PubMed    


  119. TAN AY, Elharrif K, Cardona-Guarache R, Mankad P, et al
    Persistent Proarrhythmic Neural Remodeling Despite Recovery From Premature Ventricular Contraction-Induced Cardiomyopathy.
    J Am Coll Cardiol. 2020;75:1-13.
    PubMed     Abstract available


    December 2019
  120. RUSSAK AJ, Johnson KW, Halperin JL, Percha B, et al
    Racial and Sex Differences in Stroke Risk in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2019;74:3069-3070.
    PubMed    


  121. ALKHOULI M, Friedman PA
    Ischemic Stroke Risk in Patients With Nonvalvular Atrial Fibrillation: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;74:3050-3065.
    PubMed     Abstract available


  122. GUE YX, Inoue N, Spinthakis N, Takei A, et al
    Thrombotic Profile and Oral Anticoagulation in Asian and Non-Asian Patients With Nonvalvular Atrial Fibrillation.
    J Am Coll Cardiol. 2019;74:2822-2824.
    PubMed    


  123. VOLGMAN AS, Bairey Merz CN, Benjamin EJ, Curtis AB, et al
    Sex and Race/Ethnicity Differences in Atrial Fibrillation.
    J Am Coll Cardiol. 2019;74:2812-2815.
    PubMed    


  124. GLOTZER TV
    The Naissance of Atrial Fibrillation.
    J Am Coll Cardiol. 2019;74:2782-2785.
    PubMed    


  125. DIEDERICHSEN SZ, Haugan KJ, Brandes A, Lanng MB, et al
    Natural History of Subclinical Atrial Fibrillation Detected by Implanted Loop Recorders.
    J Am Coll Cardiol. 2019;74:2771-2781.
    PubMed     Abstract available


    November 2019
  126. OBOKATA M, Reddy YNV, Shah SJ, Kaye DM, et al
    Effects of Interatrial Shunt on Pulmonary Vascular Function in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2019;74:2539-2550.
    PubMed     Abstract available


  127. QAMAR A, Antman EM, Giugliano RP
    Reply: Anticoagulants in Atrial Fibrillation and Liver Disease.
    J Am Coll Cardiol. 2019;74:2436-2437.
    PubMed    


  128. PIGNATELLI P, Pastori D, Violi F
    Anticoagulants in Atrial Fibrillation and Liver Disease.
    J Am Coll Cardiol. 2019;74:2436.
    PubMed    


  129. LIP GYH, Bhatt DL, Hohnloser SH, Kimura T, et al
    Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation Post-PCI: Time in Therapeutic Range.
    J Am Coll Cardiol. 2019;74:2431-2433.
    PubMed    


  130. CHOI EK, Lee SR, Oh S, Lip GYH, et al
    Reply: Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Liver Disease.
    J Am Coll Cardiol. 2019;74:2330-2331.
    PubMed    


  131. GUO W, Tian X, Qiu L, Li L, et al
    Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Liver Disease.
    J Am Coll Cardiol. 2019;74:2329-2330.
    PubMed    


  132. SHARMA SP, Turagam MK, Gopinathannair R, Reddy V, et al
    Direct Current Cardioversion of Atrial Fibrillation in Patients With Left Atrial Appendage Occlusion Devices.
    J Am Coll Cardiol. 2019;74:2267-2274.
    PubMed     Abstract available


  133. CALKINS H
    When it Comes to the Mortality Rates of Catheter Ablation of Atrial Fibrillation, Experience Matters.
    J Am Coll Cardiol. 2019;74:2265-2266.
    PubMed    


  134. CHENG EP, Liu CF, Yeo I, Markowitz SM, et al
    Risk of Mortality Following Catheter Ablation of Atrial Fibrillation.
    J Am Coll Cardiol. 2019;74:2254-2264.
    PubMed     Abstract available


    October 2019
  135. KUMAR S, Lim E, Covic A, Verhamme P, et al
    Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;74:2204-2215.
    PubMed     Abstract available


  136. GAGE BF
    Warfarin-Induced Fractures in Atrial Fibrillation?
    J Am Coll Cardiol. 2019;74:2159-2161.
    PubMed    


  137. BINDING C, Bjerring Olesen J, Abrahamsen B, Staerk L, et al
    Osteoporotic Fractures in Patients With Atrial Fibrillation Treated With Conventional Versus Direct Anticoagulants.
    J Am Coll Cardiol. 2019;74:2150-2158.
    PubMed     Abstract available


  138. CHAMBERLAIN AM
    Secondhand Smoke and Atrial Fibrillation: Importance of Managing Modifiable Risk Factors.
    J Am Coll Cardiol. 2019;74:1665-1666.
    PubMed    


  139. GROH CA, Vittinghoff E, Benjamin EJ, Dupuis J, et al
    Childhood Tobacco Smoke Exposure and Risk of Atrial Fibrillation in Adulthood.
    J Am Coll Cardiol. 2019;74:1658-1664.
    PubMed     Abstract available


    September 2019
  140. SARDANA M, Hsue PY, Tseng ZH, Vittinghoff E, et al
    Human Immunodeficiency Virus Infection and Incident Atrial Fibrillation.
    J Am Coll Cardiol. 2019;74:1512-1514.
    PubMed    


  141. KOTTKAMP H
    On the Atrial Fibrillation Substrate: From the "Unknown Species" to Deeper Insights Into Pathophysiology.
    J Am Coll Cardiol. 2019;74:1348-1351.
    PubMed    


  142. HIRAM R, Naud P, Xiong F, Al-U'datt D, et al
    Right Atrial Mechanisms of Atrial Fibrillation in a Rat Model of Right Heart Disease.
    J Am Coll Cardiol. 2019;74:1332-1347.
    PubMed     Abstract available


    August 2019
  143. WANG A, Green JB, Halperin JL, Piccini JP Sr, et al
    Atrial Fibrillation and Diabetes Mellitus: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;74:1107-1115.
    PubMed     Abstract available


  144. DI BIASE L, Mohanty S, Trivedi C, Romero J, et al
    Stroke Risk in Patients With Atrial Fibrillation Undergoing Electrical Isolation of the Left Atrial Appendage.
    J Am Coll Cardiol. 2019;74:1019-1028.
    PubMed     Abstract available


  145. RODES-CABAU J, Ellenbogen KA, Krahn AD, Latib A, et al
    Management of Conduction Disturbances Associated With Transcatheter Aortic Valve Replacement: JACC Scientific Expert Panel.
    J Am Coll Cardiol. 2019;74:1086-1106.
    PubMed     Abstract available


  146. DESHAIES C, Hamilton RM, Shohoudi A, Trottier H, et al
    Thromboembolic Risk After Atriopulmonary, Lateral Tunnel, and Extracardiac Conduit Fontan Surgery.
    J Am Coll Cardiol. 2019;74:1071-1081.
    PubMed     Abstract available


  147. GUO Y, Wang H, Zhang H, Liu T, et al
    Mobile Health Technology for Atrial Fibrillation Screening Using Photoplethysmography-Based Smart Devices: The HUAWEI Heart study.
    J Am Coll Cardiol. 2019 Aug 22. pii: S0735-1097(19)36365.
    PubMed     Abstract available


  148. MIYOSHI T, Maeno Y, Hamasaki T, Inamura N, et al
    Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial.
    J Am Coll Cardiol. 2019;74:874-885.
    PubMed     Abstract available


  149. ZOGHBI WA
    Should Left Atrial Size Influence the Decision to Intervene in Degenerative Mitral Regurgitation?
    J Am Coll Cardiol. 2019;74:871-873.
    PubMed    


  150. ESSAYAGH B, Antoine C, Benfari G, Messika-Zeitoun D, et al
    Prognostic Implications of Left Atrial Enlargement in Degenerative Mitral Regurgitation.
    J Am Coll Cardiol. 2019;74:858-870.
    PubMed     Abstract available


  151. NESTELBERGER T, Boeddinghaus J, Wussler D, Twerenbold R, et al
    Predicting Major Adverse Events in Patients With Acute Myocardial Infarction.
    J Am Coll Cardiol. 2019;74:842-854.
    PubMed     Abstract available


    July 2019
  152. CHOI EK, Lee SR
    DOACs in Patients With Atrial Fibrillation and Liver Disease: Time to Expand the Safety Zone?
    J Am Coll Cardiol. 2019;74:190-192.
    PubMed    


  153. QAMAR A, Antman EM, Ruff CT, Nordio F, et al
    Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease.
    J Am Coll Cardiol. 2019;74:179-189.
    PubMed     Abstract available


  154. CAPODANNO D, Huber K, Mehran R, Lip GYH, et al
    Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2019;74:83-99.
    PubMed     Abstract available


  155. HUANG B
    Atrial Fibrillation Accompanying Mitral Stenosis: Another Fortress Captured by Direct Oral Anticoagulants?
    J Am Coll Cardiol. 2019;73:3361-3362.
    PubMed    


  156. GIANCATERINO S, Hsu JC
    Valvular Atrial Fibrillation: A Confusing and Obsolete Definition.
    J Am Coll Cardiol. 2019;73:3360-3361.
    PubMed    


  157. LEE SR, Lee HJ, Choi EK, Han KD, et al
    Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Disease.
    J Am Coll Cardiol. 2019;73:3295-3308.
    PubMed     Abstract available


  158. KIM JY, Kim SH
    Reply: Off-Label Use of Direct Oral Anticoagulants in Patients With Mitral Stenosis.
    J Am Coll Cardiol. 2019;73:3362-3363.
    PubMed    


  159. ZHOU Z
    Efficacy and Safety of Direct Oral Anticoagulants in Patients With Mitral Stenosis.
    J Am Coll Cardiol. 2019;73:3362.
    PubMed    


    June 2019
  160. VERHEUGT FWA, Ten Berg JM, Storey RF, Cuisset T, et al
    Antithrombotic Agents: From Aspirin to DOACs in Coronary Artery Disease and in Atrial Fibrillation (Part I).
    J Am Coll Cardiol. 2019 Jun 27. pii: S0735-1097(19)35400.
    PubMed     Abstract available


  161. GOLD MR, Koerber SM
    Electrocardiogram in Cardiac Resynchronization Therapy: Is Non-Left Bundle Branch Block an Oversimplification?
    J Am Coll Cardiol. 2019;73:3100-3101.
    PubMed    


  162. EL-AM EA, Dispenzieri A, Grogan M, Nkomo VT, et al
    Reply: Cardiac Amyloidosis, Atrial Arrhythmias, Thrombus, and Stroke: A Vexing Problem.
    J Am Coll Cardiol. 2019;73:2911-2913.
    PubMed    


  163. RUSSO D, Limite LR, Arcari L, Autore C, et al
    Predicting the Unpredictable: How to Score the Risk of Stroke in Cardiac Amyloidosis?
    J Am Coll Cardiol. 2019;73:2910-2911.
    PubMed    


  164. CSECS I, Merkely B, Wilson BD
    Cardiac Amyloidosis and Electrical Cardioversion: Is the Thrombus There or Not?
    J Am Coll Cardiol. 2019;73:2909-2910.
    PubMed    


  165. DEFILIPPI C, Seliger S, Latta F, Peters M, et al
    High-Sensitivity Cardiac Troponin Assays Potentially Differentiate Acute From Chronic Myocardial Injury.
    J Am Coll Cardiol. 2019;73:2904-2905.
    PubMed    


    May 2019
  166. FAUCHIER L, Cinaud A, Brigadeau F, Lepillier A, et al
    Major Adverse Events With Percutaneous Left Atrial Appendage Closure in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2019;73:2638-2640.
    PubMed    


  167. BIRGERSDOTTER-GREEN U, Eskander MA
    Delayed Atrioventricular Block Following Transcatheter Aortic Valve Replacement: Risk Stratification or Crystal Ball?
    J Am Coll Cardiol. 2019;73:2548-2549.
    PubMed    


  168. REAM K, Sandhu A, Valle J, Weber R, et al
    Ambulatory Rhythm Monitoring to Detect Late High-Grade Atrioventricular Block Following Transcatheter Aortic Valve Replacement.
    J Am Coll Cardiol. 2019;73:2538-2547.
    PubMed     Abstract available


  169. ARIGA R, Tunnicliffe EM, Manohar SG, Mahmod M, et al
    Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias.
    J Am Coll Cardiol. 2019;73:2493-2502.
    PubMed     Abstract available


  170. MCKENNA WJ, Moon JC, Sulaiman A
    Understanding the Myocardial Architecture of Hypertrophic Cardiomyopathy for Clinical Care.
    J Am Coll Cardiol. 2019;73:2503-2505.
    PubMed    


  171. CRAWFORD TC
    Pacemaker Mortality After Surgical Ablation for Atrial Fibrillation: What Is Success and Failure?
    J Am Coll Cardiol. 2019;73:2436-2438.
    PubMed    


  172. DEROSE JJ JR, Mancini DM, Chang HL, Argenziano M, et al
    Pacemaker Implantation After Mitral Valve Surgery With Atrial Fibrillation Ablation.
    J Am Coll Cardiol. 2019;73:2427-2435.
    PubMed     Abstract available


  173. DEFERM S, Bertrand PB, Verbrugge FH, Verhaert D, et al
    Atrial Functional Mitral Regurgitation: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;73:2465-2476.
    PubMed     Abstract available


  174. SHINNAWI R, Shaheen N, Huber I, Shiti A, et al
    Modeling Reentry in the Short QT Syndrome With Human-Induced Pluripotent Stem Cell-Derived Cardiac Cell Sheets.
    J Am Coll Cardiol. 2019;73:2310-2324.
    PubMed     Abstract available


  175. HULOT JS
    Modeling Cardiac Arrhythmias With Organoids.
    J Am Coll Cardiol. 2019;73:2325-2327.
    PubMed    


  176. HUIZAR JF, Ellenbogen KA, Tan AY, Kaszala K, et al
    Arrhythmia-Induced Cardiomyopathy: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2019;73:2328-2344.
    PubMed     Abstract available


  177. REDDY VY, Neuzil P, de Potter T, van der Heyden J, et al
    A Percutaneous Permanent Carotid Filter for Stroke Prevention in Atrial Fibrillation: The CAPTURE Trial.
    J Am Coll Cardiol. 2019 May 8. pii: S0735-1097(19)35006.
    PubMed     Abstract available


    April 2019
  178. DE FERRARI GM, Dusi V, Ruffinazzi M, Gionti V, et al
    Physical Inactivity Is a Risk Factor for Primary Ventricular Fibrillation.
    J Am Coll Cardiol. 2019;73:2117-2118.
    PubMed    


  179. REDDY VY, Neuzil P, Koruth JS, Petru J, et al
    Pulsed Field Ablation for Pulmonary Vein Isolation in Atrial Fibrillation.
    J Am Coll Cardiol. 2019 Apr 29. pii: S0735-1097(19)34933.
    PubMed     Abstract available


  180. FRIEDMAN DJ, Pokorney SD, Khanna R, Goldstein L, et al
    Catheter Ablation of Atrial Fibrillation With and Without On-Site Cardiothoracic Surgery.
    J Am Coll Cardiol. 2019 Apr 29. pii: S0735-1097(19)33808.
    PubMed    


  181. PIERONI M, Notarstefano P, Bolognese L
    Brugada Syndrome in the Young and in the Adult: A Tale of 2 Diseases?
    J Am Coll Cardiol. 2019;73:1766-1768.
    PubMed    


  182. MAZZANTI A, Ovics P, Shauer A, Mameli S, et al
    Unexpected Risk Profile of a Large Pediatric Population With Brugada Syndrome.
    J Am Coll Cardiol. 2019;73:1868-1869.
    PubMed    


  183. MICHOWITZ Y, Milman A, Andorin A, Sarquella-Brugada G, et al
    Characterization and Management of Arrhythmic Events in Young Patients With Brugada Syndrome.
    J Am Coll Cardiol. 2019;73:1756-1765.
    PubMed     Abstract available


  184. ECKHARDT LL, Kalscheur MM
    Replacing Hardware With "Viralware".
    J Am Coll Cardiol. 2019;73:1688-1690.
    PubMed    


  185. DAWKINS JF, Hu YF, Valle J, Sanchez L, et al
    Antegrade Conduction Rescues Right Ventricular Pacing-Induced Cardiomyopathy in Complete Heart Block.
    J Am Coll Cardiol. 2019;73:1673-1687.
    PubMed     Abstract available


  186. STEVENSON WG, Tedrow UB, Reddy V, AbdelWahab A, et al
    Infusion Needle Radiofrequency Ablation for Treatment of Refractory Ventricular Arrhythmias.
    J Am Coll Cardiol. 2019;73:1413-1425.
    PubMed     Abstract available


  187. SHAH KS, Held EP
    Utilizing Biomarkers to Refine Risk Prediction in Atrial Fibrillation: A Step Toward Precision Medicine.
    J Am Coll Cardiol. 2019;73:1411-1412.
    PubMed    


  188. RAVASSA S, Ballesteros G, Lopez B, Ramos P, et al
    Combination of Circulating Type I Collagen-Related Biomarkers Is Associated With Atrial Fibrillation.
    J Am Coll Cardiol. 2019;73:1398-1410.
    PubMed     Abstract available


  189. HSIA HH, Xiong N
    Infusion Needle Ablation Catheter: An Evolution of Needs.
    J Am Coll Cardiol. 2019;73:1426-1429.
    PubMed    


  190. DEZORZI C, Boyle B, Qazi A, Luthra K, et al
    Administrative Billing Codes for Identifying Patients With Cardiac Arrest.
    J Am Coll Cardiol. 2019;73:1598-1600.
    PubMed    


    March 2019
  191. PIERONI M, Notarstefano P, Oliva A, Santangeli P, et al
    Reply: Myocardial Inflammation in Brugada Syndrome.
    J Am Coll Cardiol. 2019;73:1370.
    PubMed    


  192. MILES C, Asimaki A, Behr ER, Sheppard MN, et al
    Myocardial Inflammation in Brugada Syndrome.
    J Am Coll Cardiol. 2019;73:1369-1370.
    PubMed    


  193. MOSARLA RC, Vaduganathan M, Qamar A, Moslehi J, et al
    Anticoagulation Strategies in Patients With Cancer: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;73:1336-1349.
    PubMed     Abstract available


  194. JUNEJO RT, Braz ID, Lucas SJE, van Lieshout JJ, et al
    Impaired Cerebrovascular Reactivity in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2019;73:1230-1232.
    PubMed    


  195. GIUGLIANO RP, O'Gara PT
    DOACs in Patients With Mitral Stenosis and Atrial Fibrillation: Time for a Randomized Clinical Trial.
    J Am Coll Cardiol. 2019;73:1132-1134.
    PubMed    


  196. KIM JY, Kim SH, Myong JP, Kim YR, et al
    Outcomes of Direct Oral Anticoagulants in Patients With Mitral Stenosis.
    J Am Coll Cardiol. 2019;73:1123-1131.
    PubMed     Abstract available


  197. CONEN D, Rodondi N, Muller A, Beer JH, et al
    Relationships of Overt and Silent Brain Lesions With Cognitive Function in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2019;73:989-999.
    PubMed     Abstract available


  198. MCINTYRE WF, Healey JS, Devereaux PJ, Conen D, et al
    A Call for Randomized Trials of Oral Anticoagulation for Patients With Post-Operative Atrial Fibrillation.
    J Am Coll Cardiol. 2019;73:1105.
    PubMed    


  199. NARULA J, Ibanez B, Fuster V
    From Heart to Head, Thrombi to Emboli, and Inferences to Extrapolation.
    J Am Coll Cardiol. 2019;73:1000-1003.
    PubMed    


  200. VERHEUGT FWA
    Low Body Weight and Prescribing DOACs in Atrial Fibrillation.
    J Am Coll Cardiol. 2019;73:932-934.
    PubMed    


  201. LEE SR, Choi EK, Park CS, Han KD, et al
    Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight.
    J Am Coll Cardiol. 2019;73:919-931.
    PubMed     Abstract available


    February 2019
  202. GUGLIN M, Zucker MJ, Bazan VM, Bozkurt B, et al
    Venoarterial ECMO for Adults: JACC Scientific Expert Panel.
    J Am Coll Cardiol. 2019;73:698-716.
    PubMed     Abstract available


  203. DIENER HC, Hart RG, Koudstaal PJ, Lane DA, et al
    Atrial Fibrillation and Cognitive Function: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;73:612-619.
    PubMed     Abstract available


  204. ANDERSON KP
    Cardiac Amyloidosis and the Risks of Cardioversion.
    J Am Coll Cardiol. 2019;73:598-601.
    PubMed    


  205. EL-AM EA, Dispenzieri A, Melduni RM, Ammash NM, et al
    Direct Current Cardioversion of Atrial Arrhythmias in Adults With Cardiac Amyloidosis.
    J Am Coll Cardiol. 2019;73:589-597.
    PubMed     Abstract available


    January 2019
  206. BORGER MA, Mansour MC, Levine RA
    Atrial Fibrillation and Mitral Valve Prolapse: Time to Intervene?
    J Am Coll Cardiol. 2019;73:275-277.
    PubMed    


  207. GRIGIONI F, Benfari G, Vanoverschelde JL, Tribouilloy C, et al
    Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation.
    J Am Coll Cardiol. 2019;73:264-274.
    PubMed     Abstract available


  208. TURAGAM MK, Lakkireddy D
    Reply: Relevant Anatomic Determinants for Epicardial Left Atrial Appendage Exclusion.
    J Am Coll Cardiol. 2019;73:381.
    PubMed    


  209. PORTA-SANCHEZ A, Pizarro G, Salvador-Montanes O, Sanchez-Quintana D, et al
    Relevant Anatomic Determinants for Epicardial Left Atrial Appendage Exclusion.
    J Am Coll Cardiol. 2019;73:380-381.
    PubMed    


  210. JANUARY CT, Wann LS, Calkins H, Chen LY, et al
    2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Hea
    J Am Coll Cardiol. 2019 Jan 21. pii: S0735-1097(19)30209.
    PubMed    


  211. BONNY A, Ngantcha M, Scholtz W, Chin A, et al
    Cardiac Arrhythmias in Africa: Epidemiology, Management Challenges, and Perspectives.
    J Am Coll Cardiol. 2019;73:100-109.
    PubMed     Abstract available


  212. OVERTCHOUK P, Guedeney P, Rouanet S, Verhoye JP, et al
    Long-Term Mortality and Early Valve Dysfunction According to Anticoagulation Use: The FRANCE TAVI Registry.
    J Am Coll Cardiol. 2019;73:13-21.
    PubMed     Abstract available


    December 2018
  213. AUFFRET V, Martins RP, Daubert C, Leclercq C, et al
    Idiopathic/Iatrogenic Left Bundle Branch Block-Induced Reversible Left Ventricle Dysfunction: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2018;72:3177-3188.
    PubMed     Abstract available


  214. ARNOLD AD, Shun-Shin MJ, Keene D, Howard JP, et al
    His Resynchronization Versus Biventricular Pacing in Patients With Heart Failure and Left Bundle Branch Block.
    J Am Coll Cardiol. 2018;72:3112-3122.
    PubMed     Abstract available


  215. MILLER MA, Dukkipati SR, Turagam M, Liao SL, et al
    Arrhythmic Mitral Valve Prolapse: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2018;72.
    PubMed     Abstract available


  216. FAUCHIER L, Cinaud A, Brigadeau F, Lepillier A, et al
    Left Atrial Appendage Closure in Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:2806-2807.
    PubMed    


    November 2018
  217. LIN YC, Chien LN, Huang CY
    Reply: Optimal Dose of Rivaroxaban in Asians With Atrial Fibrillation: Further Studies Are Warranted.
    J Am Coll Cardiol. 2018;72:2682-2683.
    PubMed    


  218. HUANG Y, Mai L, Zhang Y, Cai X, et al
    Optimal Dose of Rivaroxaban in Asians With Atrial Fibrillation: Further Studies Are Warranted.
    J Am Coll Cardiol. 2018;72:2681-2682.
    PubMed    


  219. KIRCHHOF P, Bach M, Camm AJ
    Reply: Anticoagulants for Cardioembolism Prevention in Atrial Fibrillation Patients: Potential Bias From Real-World Studies.
    J Am Coll Cardiol. 2018;72:2546-2547.
    PubMed    


  220. LI HF, Hong Y
    Anticoagulants for Cardioembolism Prevention in Atrial Fibrillation Patients: Potential Bias From Real-World Studies.
    J Am Coll Cardiol. 2018;72:2545-2546.
    PubMed    


  221. JUNG H, Sung JH, Yang PS, Jang E, et al
    Stroke Risk Stratification for Atrial Fibrillation Patients With Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2018;72:2409-2411.
    PubMed    


  222. LINZ D, Brooks AG, Elliott AD, Kalman JM, et al
    Nightly Variation in Sleep Apnea Severity as Atrial Fibrillation Risk.
    J Am Coll Cardiol. 2018;72:2406-2407.
    PubMed    


    October 2018
  223. KUSUMOTO FM, Schoenfeld MH, Barrett C, Edgerton JR, et al
    2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guideli
    J Am Coll Cardiol. 2018 Oct 31. pii: S0735-1097(18)38984.
    PubMed    


  224. KUSUMOTO FM, Schoenfeld MH, Barrett C, Edgerton JR, et al
    2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart R
    J Am Coll Cardiol. 2018 Oct 31. pii: S0735-1097(18)38985.
    PubMed    


  225. SLOTWINER DJ, Raitt MH, Del-Carpio Munoz F, Mulpuru SK, et al
    Impact of Physiologic Pacing Versus Right Ventricular Pacing Among Patients With Left Ventricular Ejection Fraction Greater Than 35%: A Systematic Review for the 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia
    J Am Coll Cardiol. 2018 Oct 31. pii: S0735-1097(18)38988.
    PubMed     Abstract available


  226. CURTIS AB, Khan HA
    Should All Atrial Fibrillation Be Considered a Life-Long Problem Requiring Prophylaxis Against Thromboembolism?
    J Am Coll Cardiol. 2018;72:2037-2039.
    PubMed    


  227. BUTT JH, Olesen JB, Havers-Borgersen E, Gundlund A, et al
    Risk of Thromboembolism Associated With Atrial Fibrillation Following Noncardiac Surgery.
    J Am Coll Cardiol. 2018;72:2027-2036.
    PubMed     Abstract available


  228. JI-YOUNG LEE C, Torp-Pedersen C
    Reply: DOACs Versus Warfarin in Preventing Myocardial Infarction: Are the Benefits Worth the Price?
    J Am Coll Cardiol. 2018;72:2093-2094.
    PubMed    


  229. YE ZL, Guo WQ, Li L
    Non-VKA Oral Anticoagulant and Risk of Myocardial Infarction: Paradoxical Procoagulant Effect of Warfarin?
    J Am Coll Cardiol. 2018;72:2093.
    PubMed    


  230. ALOIA E
    DOACs Versus Warfarin in Preventing Myocardial Infarction: Are the Benefits Worth the Price?
    J Am Coll Cardiol. 2018;72:2092-2093.
    PubMed    


  231. CHEN ST, Melloni C
    Atrial Fibrillation in Cancer Patients: Recognizing Gaps in Care.
    J Am Coll Cardiol. 2018;72:1923-1925.
    PubMed    


  232. O'NEAL WT, Claxton JS, Sandesara PB, MacLehose RF, et al
    Provider Specialty, Anticoagulation, and Stroke Risk in Patients With Atrial Fibrillation and Cancer.
    J Am Coll Cardiol. 2018;72:1913-1922.
    PubMed     Abstract available


  233. KOTECHA D, Pollack CV Jr, De Caterina R, Renda G, et al
    Direct Oral Anticoagulants Halve Thromboembolic Events After Cardioversion of AF Compared With Warfarin.
    J Am Coll Cardiol. 2018;72:1984-1986.
    PubMed    


  234. SINDET-PEDERSEN C, Lamberts M, Staerk L, Nissen Bonde A, et al
    Combining Oral Anticoagulants With Platelet Inhibitors in Patients With Atrial Fibrillation and Coronary Disease.
    J Am Coll Cardiol. 2018;72:1790-1800.
    PubMed     Abstract available


    September 2018
  235. CORBALAN R, Nicolau JC, Lopez-Sendon J, Garcia-Castillo A, et al
    Edoxaban Versus Warfarin in Latin American Patients With Atrial Fibrillation: The ENGAGE AF-TIMI 48 Trial.
    J Am Coll Cardiol. 2018;72:1466-1475.
    PubMed     Abstract available


  236. BUMGARNER JM, Lambert CT, Tarakji KG
    Reply: The Smartwatch Will See You Now: Implications of Mass Screening for Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:1434-1435.
    PubMed    


  237. GIANCATERINO SK, Hsu JC
    The Smartwatch Will See You Now: Implications of Mass Screening for Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:1433-1434.
    PubMed    


  238. BONDE AN, Staerk L, Lee CJ, Vinding NE, et al
    Outcomes Among Patients With Atrial Fibrillation and Appropriate Anticoagulation Control.
    J Am Coll Cardiol. 2018;72:1357-1365.
    PubMed     Abstract available


  239. TURAGAM MK, Vuddanda V, Verberkmoes N, Ohtsuka T, et al
    Epicardial Left Atrial Appendage Exclusion Reduces Blood Pressure in Patients With Atrial Fibrillation and Hypertension.
    J Am Coll Cardiol. 2018;72:1346-1353.
    PubMed     Abstract available


  240. KIM D, Yang PS, Kim TH, Jang E, et al
    Ideal Blood Pressure in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:1233-1245.
    PubMed     Abstract available


  241. PHILLIPS RA, Arnold RM, Peterson LE
    Hypertension Guidelines: The Threads That Bind Them.
    J Am Coll Cardiol. 2018;72:1246-1251.
    PubMed    


    August 2018
  242. STEENSIG K, Olesen KKW, Thim T, Nielsen JC, et al
    Coronary artery disease is independent risk factor for stroke among patients with atrial fibrillation.
    J Am Coll Cardiol. 2018 Aug 23. pii: S0735-1097(18)36961.
    PubMed    


  243. LEE SR, Choi EK, Han KD, Jung JH, et al
    Edoxaban in Asian Patients With Atrial Fibrillation: Effectiveness and Safety.
    J Am Coll Cardiol. 2018;72:838-853.
    PubMed     Abstract available


  244. GANDJBAKHCH E, Redheuil A, Pousset F, Charron P, et al
    Clinical Diagnosis, Imaging, and Genetics of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2018;72:784-804.
    PubMed     Abstract available


  245. COOKE JP, Sukhovershin RA
    Novel Markers for Adverse Events in Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:734-737.
    PubMed    


  246. HOROWITZ JD, De Caterina R, Heresztyn T, Alexander JH, et al
    Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation: An ARISTOTLE Substudy.
    J Am Coll Cardiol. 2018;72:721-733.
    PubMed     Abstract available


  247. GUHA A, Derbala MH, Zhao Q, Wiczer TE, et al
    Ventricular Arrhythmias Following Ibrutinib Initiation for Lymphoid Malignancies.
    J Am Coll Cardiol. 2018;72:697-698.
    PubMed    


  248. ALBERT CM
    Ranolazine in Patients With Implantable Cardioverter-Defibrillators: Ready for Prime Time?
    J Am Coll Cardiol. 2018;72:646-649.
    PubMed    


    July 2018
  249. LIN YC, Chien SC, Hsieh YC, Shih CM, et al
    Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:477-485.
    PubMed     Abstract available


  250. FAUCHIER L, Cinaud A, Brigadeau F, Lepillier A, et al
    Reply: Device-Related Thrombus After Percutaneous Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:474-475.
    PubMed    


  251. KEA B, Lin AL, Olshansky B, Malveau S, et al
    Stroke Prophylaxis After a New Emergency Department Diagnosis of Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:471-472.
    PubMed    


  252. RENDA G, De Caterina R
    Sex Implications in the Response to Anticoagulant Therapy in Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:283-286.
    PubMed    


  253. LAW SWY, Lau WCY, Wong ICK, Lip GYH, et al
    Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:271-282.
    PubMed     Abstract available


  254. KENT AP, Brueckmann M, Fraessdorf M, Connolly SJ, et al
    Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:255-267.
    PubMed     Abstract available


  255. HEALEY JS
    Stroke Prevention in Atrial Fibrillation: What Is Real World, and What Do Real-World Data Reveal?
    J Am Coll Cardiol. 2018;72:154-155.
    PubMed    


  256. KIRCHHOF P, Radaideh G, Kim YH, Lanas F, et al
    Global Prospective Safety Analysis of Rivaroxaban.
    J Am Coll Cardiol. 2018;72:141-153.
    PubMed     Abstract available


  257. LEE CJ, Gerds TA, Carlson N, Bonde AN, et al
    Risk of Myocardial Infarction in Anticoagulated Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:17-26.
    PubMed     Abstract available


  258. LOPES RD, Rordorf R, De Ferrari GM, Leonardi S, et al
    Reply: Digoxin Use in Atrial Fibrillation: Minimizing and Refining its Use When Still Needed.
    J Am Coll Cardiol. 2018;72:125-126.
    PubMed    


  259. HOHNLOSER SH, Eikelboom JW
    Direct Oral Anticoagulants and Myocardial Infarction: The Dust Is Settling.
    J Am Coll Cardiol. 2018;72:27-28.
    PubMed    


    June 2018
  260. TURAGAM MK, Velagapudi P, Kar S, Holmes D, et al
    Cardiovascular Therapies Targeting Left Atrial Appendage.
    J Am Coll Cardiol. 2018 Jun 25. pii: S0735-1097(18)35139.
    PubMed     Abstract available


  261. ALKHOULI M, Noseworthy PA, Rihal CS, Holmes DR Jr, et al
    Stroke Prevention in Nonvalvular Atrial Fibrillation: A Stakeholder Perspective.
    J Am Coll Cardiol. 2018;71:2790-2801.
    PubMed     Abstract available


  262. MCCONNELL MV, Turakhia MP, Harrington RA, King AC, et al
    Mobile Health Advances in Physical Activity, Fitness, and Atrial Fibrillation: Moving Hearts.
    J Am Coll Cardiol. 2018;71:2691-2701.
    PubMed     Abstract available


  263. GLOTZER TV
    The Cacophony of Silent Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:2612-2615.
    PubMed    


  264. WONG JA, Conen D, Van Gelder IC, McIntyre WF, et al
    Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure.
    J Am Coll Cardiol. 2018;71:2603-2611.
    PubMed     Abstract available


    May 2018
  265. MELA T
    Smartwatches in the Fight Against Atrial Fibrillation: The Little Watch That Could.
    J Am Coll Cardiol. 2018;71:2389-2391.
    PubMed    


  266. SZE E, Daubert JP
    Reply: Early Cardiac Resynchronization Therapy for Left Bundle Branch Block-Associated Cardiomyopathies.
    J Am Coll Cardiol. 2018;71:1945-1946.
    PubMed    


  267. WANG NC, Adelstein EC, Singh M, Voigt AH, et al
    Left Bundle Branch Block-Associated Cardiomyopathies and Early Cardiac Resynchronization Therapy: Conceptualizing a Tailored Approach.
    J Am Coll Cardiol. 2018;71:1943-1944.
    PubMed    


  268. CHATZIDOU S, Kontogiannis C, Tsilimigras DI, Georgiopoulos G, et al
    Propranolol Versus Metoprolol for Treatment of Electrical Storm in Patients With Implantable Cardioverter-Defibrillator.
    J Am Coll Cardiol. 2018;71:1897-1906.
    PubMed     Abstract available


    April 2018
  269. GRACE AA, Matthews GDK
    Phenotypic Landscape and Risk Management in Long QT Syndrome: Nudging Forward.
    J Am Coll Cardiol. 2018;71:1672-1675.
    PubMed    


  270. MAZZANTI A, Maragna R, Vacanti G, Monteforte N, et al
    Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome.
    J Am Coll Cardiol. 2018;71:1663-1671.
    PubMed     Abstract available


  271. FAUCHIER L, Cinaud A, Brigadeau F, Lepillier A, et al
    Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:1528-1536.
    PubMed     Abstract available


  272. YU L, Zhou L, Meng G, Jiang H, et al
    Reply: Optogenetic Neuromodulation of Stellate Ganglia for Patients With Ventricular Arrhythmias, Atrial Fibrillation, Angina, and Takotsubo?
    J Am Coll Cardiol. 2018;71:1496-1497.
    PubMed    


  273. MADIAS JE
    Optogenetic Neuromodulation of Stellate Ganglia for Patients With Ventricular Arrhythmias, Atrial Fibrillation, Angina, and Takotsubo?
    J Am Coll Cardiol. 2018;71:1495-1496.
    PubMed    


    March 2018
  274. TAYAL B, Gorcsan J 3rd, Bax JJ, Risum N, et al
    Cardiac Resynchronization Therapy in Patients With Heart Failure and Narrow QRS Complexes.
    J Am Coll Cardiol. 2018;71:1325-1333.
    PubMed     Abstract available


  275. PRABHU S, Kistler PM
    Reply: Beyond Pulmonary Vein Isolation During Catheter Ablation in Atrial Fibrillation and Systolic Dysfunction.
    J Am Coll Cardiol. 2018;71:1293-1294.
    PubMed    


  276. ALDAAS OM, Padwal J, Hsu JC
    Beyond Pulmonary Vein Isolation During Catheter Ablation in Atrial Fibrillation and Systolic Dysfunction.
    J Am Coll Cardiol. 2018;71:1292-1293.
    PubMed    


  277. TURAKHIA MP
    Digoxin in Atrial Fibrillation?: Leave it Out of the Medicine Cabinet.
    J Am Coll Cardiol. 2018;71:1075-1077.
    PubMed    


  278. LOPES RD, Rordorf R, De Ferrari GM, Leonardi S, et al
    Digoxin and Mortality in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:1063-1074.
    PubMed     Abstract available


  279. MOGENSEN UM, Kober L, McMurray JJV
    Reply: Time for an "Atrial-Watchful" Approach for Heart Failure Patients With a Cardiac Implantable Electronic Device.
    J Am Coll Cardiol. 2018;71:1188-1189.
    PubMed    


  280. CANEPA M, Bertero E, Brunelli C, Ameri P, et al
    Time for an "Atrial-Watchful" Approach for Heart Failure Patients With a Cardiac Implantable Electronic Device.
    J Am Coll Cardiol. 2018;71:1187-1188.
    PubMed    


  281. BUMGARNER JM, Lambert CT, Hussein AA, Cantillon DJ, et al
    Automated Atrial Fibrillation Detection Algorithm Using Smartwatch Technology.
    J Am Coll Cardiol. 2018 Mar 7. pii: S0735-1097(18)33486.
    PubMed     Abstract available


  282. KING JB, Marrouche N
    Reply: What Is the Biological Relationship Between Left Atrial Fibrosis and Stroke in Atrial Fibrillation?
    J Am Coll Cardiol. 2018;71:1054-1056.
    PubMed    


  283. REN JF, Callans DJ, Marchlinski FE
    What Is the Biological Relationship Between Left Atrial Fibrosis and Stroke in Atrial Fibrillation?
    J Am Coll Cardiol. 2018;71:1053-1054.
    PubMed    


    February 2018
  284. VERMA A, Bhatt DL, Verma S
    Long-Term Outcomes of Post-Operative Atrial Fibrillation: Guilty as Charged.
    J Am Coll Cardiol. 2018;71:749-751.
    PubMed    


  285. KOSMIDOU I, Chen S, Kappetein AP, Serruys PW, et al
    New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial.
    J Am Coll Cardiol. 2018;71:739-748.
    PubMed     Abstract available


  286. FERREIRA JP, Girerd N, Gregson J, Latar I, et al
    Stroke Risk in Patients With Reduced Ejection Fraction After Myocardial Infarction Without Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:727-735.
    PubMed     Abstract available


  287. PASTORI D, Nocella C, Farcomeni A, Bartimoccia S, et al
    Reply: LDL-Cholesterol and Atherosclerotic Cardiovascular Disease: Innocent Bystander or Essential Ingredient?
    J Am Coll Cardiol. 2018;71:706-707.
    PubMed    


  288. EGOM EE
    LDL-Cholesterol and Atherosclerotic Cardiovascular Disease: Innocent Bystander or Essential Ingredient.
    J Am Coll Cardiol. 2018;71:705-706.
    PubMed    


    January 2018
  289. LINDE C, Braunschweig F
    Cardiomyopathy and Left Bundle Branch Block: A Farewell to Drugs?
    J Am Coll Cardiol. 2018;71:318-320.
    PubMed    


  290. SZE E, Samad Z, Dunning A, Campbell KB, et al
    Impaired Recovery of Left Ventricular Function in Patients With Cardiomyopathy and Left Bundle Branch Block.
    J Am Coll Cardiol. 2018;71:306-317.
    PubMed     Abstract available


  291. SHIN JI, Luo S, Alexander GC, Inker LA, et al
    Direct Oral Anticoagulants and Risk of Acute Kidney Injury in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:251-252.
    PubMed    


  292. GONZALEZ CORCIA MC, Sieira J, Pappaert G, de Asmundis C, et al
    Implantable Cardioverter-Defibrillators in Children and Adolescents With Brugada Syndrome.
    J Am Coll Cardiol. 2018;71:148-157.
    PubMed     Abstract available


  293. GAGE BF
    Stroke Prediction Rules in Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:133-134.
    PubMed    


  294. CHAO TF, Lip GYH, Liu CJ, Lin YJ, et al
    Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:122-132.
    PubMed     Abstract available


    December 2017
  295. KABIR RA, Doytchinova A, Liu X, Adams D, et al
    Crescendo Skin Sympathetic Nerve Activity and Ventricular Arrhythmia.
    J Am Coll Cardiol. 2017;70:3201-3202.
    PubMed    


  296. BRUGADA P
    Short QT Syndrome and Hydroquinidine: Rare Diseases and Unavailable Drugs.
    J Am Coll Cardiol. 2017;70:3016-3017.
    PubMed    


  297. MAZZANTI A, Maragna R, Vacanti G, Kostopoulou A, et al
    Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome.
    J Am Coll Cardiol. 2017;70:3010-3015.
    PubMed     Abstract available


  298. REDDY VY, Doshi SK, Kar S, Gibson DN, et al
    5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    J Am Coll Cardiol. 2017;70:2964-2975.
    PubMed     Abstract available


  299. KHAIRY P
    Reply: Atrial Fibrillation: The Next Epidemic for Patients With Congenital Heart Disease.
    J Am Coll Cardiol. 2017;70:2950-2951.
    PubMed    


  300. TEUWEN CP, de Groot NMS
    Atrial Fibrillation: The Next Epidemic for Patients With Congenital Heart Disease.
    J Am Coll Cardiol. 2017;70:2949-2950.
    PubMed    


  301. SANDERS P, Elliott AD, Linz D
    Upstream Targets to Treat Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:2906-2908.
    PubMed    


  302. TAKEMOTO Y, Ramirez RJ, Kaur K, Salvador-Montanes O, et al
    Eplerenone Reduces Atrial Fibrillation Burden Without Preventing Atrial Electrical Remodeling.
    J Am Coll Cardiol. 2017;70:2893-2905.
    PubMed     Abstract available


  303. DUKKIPATI SR, Koruth JS, Choudry S, Miller MA, et al
    Catheter Ablation of Ventricular Tachycardia in Structural Heart Disease: Indications, Strategies, and Outcomes-Part II.
    J Am Coll Cardiol. 2017;70:2924-2941.
    PubMed     Abstract available


  304. DUKKIPATI SR, Choudry S, Koruth JS, Miller MA, et al
    Catheter Ablation of Ventricular Tachycardia in Structurally Normal Hearts: Indications, Strategies, and Outcomes-Part I.
    J Am Coll Cardiol. 2017;70:2909-2923.
    PubMed     Abstract available


  305. YU L, Zhou L, Cao G, Po SS, et al
    Optogenetic Modulation of Cardiac Sympathetic Nerve Activity to Prevent Ventricular Arrhythmias.
    J Am Coll Cardiol. 2017;70:2778-2790.
    PubMed     Abstract available


    November 2017
  306. YAO X, Shah ND, Sangaralingham LR, Gersh BJ, et al
    Reply: NOAC Dosing in Patients With Atrial Fibrillation and Renal Dysfunction.
    J Am Coll Cardiol. 2017;70:2734-2735.
    PubMed    


  307. SHROFF GR
    NOAC Dosing in Atrial Fibrillation and Renal Dysfunction: What Measure Are You Using?
    J Am Coll Cardiol. 2017;70:2733-2734.
    PubMed    


  308. HUSSAIN A, Jain SK, Wang NC
    Improved Outcomes With Cardiology Care in Newly Diagnosed Atrial Fibrillation: Is Tachycardia-Induced Cardiomyopathy Underestimated?
    J Am Coll Cardiol. 2017;70:2730.
    PubMed    


  309. PERINO AC, Turakhia MP
    Reply: Improved Outcomes With Cardiology Care in Newly Diagnosed Atrial Fibrillation: Is Tachycardia-Induced Cardiomyopathy Underestimated?
    J Am Coll Cardiol. 2017;70:2730-2731.
    PubMed    


  310. WALSH M, Connolly SJ
    Another Dimension of Safety in the Prescription of Anticoagulants for Nonvalvular Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:2633-2635.
    PubMed    


  311. YAO X, Tangri N, Gersh BJ, Sangaralingham LR, et al
    Renal Outcomes in Anticoagulated Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:2621-2632.
    PubMed     Abstract available


  312. MOGENSEN UM, Jhund PS, Abraham WT, Desai AS, et al
    Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2017;70:2490-2500.
    PubMed     Abstract available


    October 2017
  313. ABU-OMAR Y, Thorpe BS, Freeman C, Mills C, et al
    Recovery of Left Atrial Contractile Function After Maze Surgery in Persistent Longstanding Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:2309-2311.
    PubMed    


  314. AL-KHATIB SM, Stevenson WG, Ackerman MJ, Bryant WJ, et al
    2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the
    J Am Coll Cardiol. 2017 Oct 25. pii: S0735-1097(17)41306.
    PubMed    


  315. MILAN D
    The Com-PLEC-sity of Atrial Fibrillation Genetics.
    J Am Coll Cardiol. 2017;70:2169-2170.
    PubMed    


  316. THOROLFSDOTTIR RB, Sveinbjornsson G, Sulem P, Helgadottir A, et al
    A Missense Variant in PLEC Increases Risk of Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:2157-2168.
    PubMed     Abstract available


  317. KUSUMOTO FM, Bailey KR, Chaouki AS, Deshmukh AJ, et al
    Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical P
    J Am Coll Cardiol. 2017 Oct 24. pii: S0735-1097(17)41304.
    PubMed     Abstract available


  318. AL-KHATIB SM, Stevenson WG, Ackerman MJ, Bryant WJ, et al
    2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice
    J Am Coll Cardiol. 2017 Oct 24. pii: S0735-1097(17)41305.
    PubMed    


  319. LAVIE CJ, Pandey A, Lau DH, Alpert MA, et al
    Obesity and Atrial Fibrillation Prevalence, Pathogenesis, and Prognosis: Effects of Weight Loss and Exercise.
    J Am Coll Cardiol. 2017;70:2022-2035.
    PubMed     Abstract available


  320. HERNANDEZ-OJEDA J, Arbelo E, Borras R, Berne P, et al
    Patients With Brugada Syndrome and Implanted Cardioverter-Defibrillators: Long-Term Follow-Up.
    J Am Coll Cardiol. 2017;70:1991-2002.
    PubMed     Abstract available


  321. BARON-ESQUIVIAS G, Morillo CA, Moya-Mitjans A, Martinez-Alday J, et al
    Dual-Chamber Pacing With Closed Loop Stimulation in Recurrent Reflex Vasovagal Syncope: The SPAIN Study.
    J Am Coll Cardiol. 2017;70:1720-1728.
    PubMed     Abstract available


    September 2017
  322. PAQUETTE M, Riou Franca L, Teutsch C, Diener HC, et al
    Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:1573-1583.
    PubMed     Abstract available


  323. NICHOL G, Sayre MR, Guerra F, Poole J, et al
    Defibrillation for Ventricular Fibrillation: A Shocking Update.
    J Am Coll Cardiol. 2017;70:1496-1509.
    PubMed     Abstract available


  324. PASTORI D, Nocella C, Farcomeni A, Bartimoccia S, et al
    Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:1455-1462.
    PubMed     Abstract available


  325. BOCCHI EA, Bestetti RB, Scanavacca MI, Cunha Neto E, et al
    Chronic Chagas Heart Disease Management: From Etiology to Cardiomyopathy Treatment.
    J Am Coll Cardiol. 2017;70:1510-1524.
    PubMed     Abstract available


  326. DEBATY G, Labarere J, Frascone RJ, Wayne MA, et al
    Long-Term Prognostic Value of Gasping During Out-of-Hospital Cardiac Arrest.
    J Am Coll Cardiol. 2017;70:1467-1476.
    PubMed     Abstract available


  327. GURBEL PA, Navarese EP, Tantry US
    Exploration of PCSK9 as a Cardiovascular Risk Factor: Is There a Link to the Platelet?
    J Am Coll Cardiol. 2017;70:1463-1466.
    PubMed    


  328. BLOOMGARDEN ZT, Kosiborod MN, Handelsman Y
    Concomitant Diabetes and Atrial Fibrillation: No Sugarcoating the Bittersweet Reality.
    J Am Coll Cardiol. 2017;70:1336-1338.
    PubMed    


  329. ECHOUFFO-TCHEUGUI JB, Shrader P, Thomas L, Gersh BJ, et al
    Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry.
    J Am Coll Cardiol. 2017;70:1325-1335.
    PubMed     Abstract available


  330. NAZARIAN S, Zghaib T
    Is Atrial Fibrillation a Necessary Component of the Thrombogenic Atrium?
    J Am Coll Cardiol. 2017;70:1322-1324.
    PubMed    


  331. KING JB, Azadani PN, Suksaranjit P, Bress AP, et al
    Left Atrial Fibrosis and Risk of Cerebrovascular and Cardiovascular Events in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:1311-1321.
    PubMed     Abstract available


  332. ESCANDE W, Boveda S, Defaye P, Leclercq C, et al
    Outcomes in Guideline-Based Versus Off-Guideline Primary Prevention Implantable Cardioverter-Defibrillator Recipients.
    J Am Coll Cardiol. 2017;70:1302-1303.
    PubMed    


    August 2017
  333. DESIMONE CV, Graff-Radford J, El-Harasis MA, Rabinstein AA, et al
    Cerebral Amyloid Angiopathy: Diagnosis, Clinical Implications, and Management Strategies in Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:1173-1182.
    PubMed     Abstract available


  334. YANNOPOULOS D, Bartos JA, Raveendran G, Conterato M, et al
    Coronary Artery Disease in Patients With Out-of-Hospital Refractory Ventricular Fibrillation Cardiac Arrest.
    J Am Coll Cardiol. 2017;70:1109-1117.
    PubMed     Abstract available


  335. WAZNI O, Chung MK
    Catheter Ablation for Rate Controlled Atrial Fibrillation: New Horizon in Heart Failure Treatment.
    J Am Coll Cardiol. 2017 Aug 22. pii: S0735-1097(17)39348.
    PubMed    


  336. PRABHU S, Taylor AJ, Costello BT, Kaye DM, et al
    Catheter Ablation Versus Medical Rate control in Atrial Fibrillation and Systolic Dysfunction (CAMERA-MRI).
    J Am Coll Cardiol. 2017 Aug 22. pii: S0735-1097(17)39349.
    PubMed     Abstract available


  337. SILKA MJ, Bar-Cohen Y
    Prevalence of Atrial Fibrillation and Permanent Atrial Arrhythmias in Congenital Heart Disease: Sequel or Series?
    J Am Coll Cardiol. 2017;70:866-868.
    PubMed    


  338. LABOMBARDA F, Hamilton R, Shohoudi A, Aboulhosn J, et al
    Increasing Prevalence of Atrial Fibrillation and Permanent Atrial Arrhythmias in Congenital Heart Disease.
    J Am Coll Cardiol. 2017;70:857-865.
    PubMed     Abstract available


  339. POOLE JE, Prutkin JM
    Subcutaneous Implantable Cardioverter-Defibrillator Finding a Place in Sudden Cardiac Death Prevention: Emerging or Emerged?
    J Am Coll Cardiol. 2017;70:842-844.
    PubMed    


  340. BOERSMA L, Barr C, Knops R, Theuns D, et al
    Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry: The EFFORTLESS Study.
    J Am Coll Cardiol. 2017;70:830-841.
    PubMed     Abstract available


  341. IWASAWA J, Koruth JS, Petru J, Dujka L, et al
    Temperature-Controlled Radiofrequency Ablation for Pulmonary Vein Isolation in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:542-553.
    PubMed     Abstract available


    July 2017
  342. SCHWARTZ PJ, Dagradi F, Castelletti S
    Evolution in Managing Long QT Syndrome: From Registries to Centers of Excellence.
    J Am Coll Cardiol. 2017;70:463-465.
    PubMed    


  343. ROHATGI RK, Sugrue A, Bos JM, Cannon BC, et al
    Contemporary Outcomes in Patients With Long QT Syndrome.
    J Am Coll Cardiol. 2017;70:453-462.
    PubMed     Abstract available


  344. SEKI A, Ishikawa T, Daumy X, Mishima H, et al
    Progressive Atrial Conduction Defects Associated With Bone Malformation Caused by a Connexin-45 Mutation.
    J Am Coll Cardiol. 2017;70:358-370.
    PubMed     Abstract available


  345. EPPINGA RN, Hartman MHT, Verweij N, van der Harst JJ, et al
    Refining Thromboembolic Risk in the General Population.
    J Am Coll Cardiol. 2017;70:403-404.
    PubMed    


  346. WHANG W
    Opportunities to Improve Outcomes in Atrial Fibrillation: Provider Specialty and Beyond.
    J Am Coll Cardiol. 2017;70:87-88.
    PubMed    


  347. PERINO AC, Fan J, Schmitt SK, Askari M, et al
    Treating Specialty and Outcomes in Newly Diagnosed Atrial Fibrillation: From the TREAT-AF Study.
    J Am Coll Cardiol. 2017;70:78-86.
    PubMed     Abstract available


    June 2017
  348. MILLER MA, Palaniswamy C, Dukkipati SR, Balulad S, et al
    Subcutaneous Implantable Cardioverter-Defibrillator Implantation Without Defibrillation Testing.
    J Am Coll Cardiol. 2017;69:3118-3119.
    PubMed    


  349. VASEGHI M, Barwad P, Malavassi Corrales FJ, Tandri H, et al
    Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmias.
    J Am Coll Cardiol. 2017;69:3070-3080.
    PubMed     Abstract available


  350. VIJAYARAMAN P, Bordachar P, Ellenbogen KA
    The Continued Search for Physiological Pacing: Where Are We Now?
    J Am Coll Cardiol. 2017;69:3099-3114.
    PubMed     Abstract available


  351. HALPERIN JL
    Preventing Myocardial Infarction in Patients With Atrial Fibrillation: Another Piece of the Puzzle.
    J Am Coll Cardiol. 2017;69:2910-2912.
    PubMed    


  352. LEE CJ, Pallisgaard JL, Olesen JB, Carlson N, et al
    Antithrombotic Therapy and First Myocardial Infarction in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2901-2909.
    PubMed     Abstract available


  353. FILIPPATOS G, Farmakis D
    How to Use Beta-Blockers in Heart Failure With Reduced Ejection Fraction and Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2897-2900.
    PubMed    


  354. YAO X, Shah ND, Sangaralingham LR, Gersh BJ, et al
    Non-Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction.
    J Am Coll Cardiol. 2017;69:2779-2790.
    PubMed     Abstract available


    May 2017
  355. SOLOMON SD, Chatterjee NA
    Who Benefits From Implantable Cardioverter-Defibrillators?: Integrating Absolute, Proportional, and Competing Risk.
    J Am Coll Cardiol. 2017;69:2619-2621.
    PubMed    


  356. BILCHICK KC, Wang Y, Cheng A, Curtis JP, et al
    Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators.
    J Am Coll Cardiol. 2017;69:2606-2618.
    PubMed     Abstract available


  357. O'KEEFE JH, DiNicolantonio JJ
    Alcohol and Atrial Fibrillation: Mitigating the Risk.
    J Am Coll Cardiol. 2017;69:2578.
    PubMed    


  358. NATTEL S
    Atrial Fibrillation and Body Composition: Is it Fat or Lean That Ultimately Determines the Risk?
    J Am Coll Cardiol. 2017;69:2498-2501.
    PubMed    


  359. FENGER-GRON M, Overvad K, Tjonneland A, Frost L, et al
    Lean Body Mass Is the Predominant Anthropometric Risk Factor for Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2488-2497.
    PubMed     Abstract available


  360. PETERSON ED, Pokorney SD
    New Treatment Options Fail to Close the Anticoagulation Gap in Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2485-2487.
    PubMed    


  361. MARZEC LN, Wang J, Shah ND, Chan PS, et al
    Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2475-2484.
    PubMed     Abstract available


  362. DORKS M, Jobski K, Herget-Rosenthal S, Hoffmann F, et al
    Mortality and Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin.
    J Am Coll Cardiol. 2017;69:2471.
    PubMed    


  363. CHAN YH, Kuo CT
    Reply: Mortality and Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin.
    J Am Coll Cardiol. 2017;69:2471-2472.
    PubMed    


  364. MUELLER KAL, Heinzmann D, Klingel K, Fallier-Becker P, et al
    Histopathological and Immunological Characteristics of Tachycardia-Induced Cardiomyopathy.
    J Am Coll Cardiol. 2017;69:2160-2172.
    PubMed     Abstract available


  365. SANTANGELI P, Frankel DS, Tung R, Vaseghi M, et al
    Early Mortality After Catheter Ablation of Ventricular Tachycardia in Patients With Structural Heart Disease.
    J Am Coll Cardiol. 2017;69:2105-2115.
    PubMed     Abstract available


    April 2017
  366. HUCKER WJ, Hanley A, Ellinor PT
    Improving Atrial Fibrillation Therapy: Is There a Gene for That?
    J Am Coll Cardiol. 2017;69:2088-2095.
    PubMed     Abstract available


  367. SUNDARAM V, Sahadevan J, Waldo AL, Stukenborg GJ, et al
    Implantable Cardioverter-Defibrillators With Versus Without Resynchronization Therapy in Patients With a QRS Duration >180 ms.
    J Am Coll Cardiol. 2017;69:2026-2036.
    PubMed     Abstract available


  368. HOBBELT AH, Spronk HM, Crijns HJ, Ten Cate H, et al
    Prethrombotic State in Young Very Low-Risk Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:1990-1992.
    PubMed    


  369. DU X, Dong J, Ma C
    Is Atrial Fibrillation a Preventable Disease?
    J Am Coll Cardiol. 2017;69:1968-1982.
    PubMed     Abstract available


  370. LORBERBAUM T, Tatonetti NP
    Reply: Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome and Torsades de Pointes Risk.
    J Am Coll Cardiol. 2017;69:1877-1878.
    PubMed    


  371. LAZZERINI PE, Bertolozzi I, Rossi M, Capecchi PL, et al
    Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk.
    J Am Coll Cardiol. 2017;69:1876-1877.
    PubMed    


  372. SANTANGELI P, Rame JE, Birati EY, Marchlinski FE, et al
    Management of Ventricular Arrhythmias in Patients With Advanced Heart Failure.
    J Am Coll Cardiol. 2017;69:1842-1860.
    PubMed     Abstract available


  373. DRIESSEN AH, Berger WR, Chan Pin Yin DR, Piersma FR, et al
    Electrophysiologically Guided Thoracoscopic Surgery for Advanced Atrial Fibrillation: 5-Year Follow-up.
    J Am Coll Cardiol. 2017;69:1753-1754.
    PubMed    


  374. FLETCHER G
    Atrial Fibrillation: A Threat to the Failing Heart?
    J Am Coll Cardiol. 2017;69:1692-1693.
    PubMed    


  375. LUO N, Merrill P, Parikh KS, Whellan DJ, et al
    Exercise Training in Patients With Chronic Heart Failure and Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:1683-1691.
    PubMed     Abstract available


    March 2017
  376. DE CATERINA R, Renda G, Carnicelli AP, Nordio F, et al
    Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial.
    J Am Coll Cardiol. 2017;69:1372-1382.
    PubMed     Abstract available


  377. ARBUSTINI E, Favalli V, Narula N, Serio A, et al
    Reply: A Distinct Cardiomyopathy: HCN4 Syndrome Comprising Myocardial Noncompaction, Bradycardia, Mitral Valve Defects, and Aortic Dilation.
    J Am Coll Cardiol. 2017;69:1210-1211.
    PubMed    


  378. SCHWEIZER PA, Koenen M, Katus HA, Thomas D, et al
    A Distinct Cardiomyopathy: HCN4 Syndrome Comprising Myocardial Noncompaction, Bradycardia, Mitral Valve Defects, and Aortic Dilation.
    J Am Coll Cardiol. 2017;69:1209-1210.
    PubMed    


    February 2017
  379. SHARMA S, Drezner JA, Baggish A, Papadakis M, et al
    International Recommendations for Electrocardiographic Interpretation in Athletes.
    J Am Coll Cardiol. 2017;69:1057-1075.
    PubMed     Abstract available


  380. HUISMAN MV, Rothman KJ, Paquette M, Teutsch C, et al
    The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2.
    J Am Coll Cardiol. 2017;69:777-785.
    PubMed     Abstract available


  381. VADUGANATHAN M, Patel RB, Michel A, Shah SJ, et al
    Mode of Death in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2017;69:556-569.
    PubMed     Abstract available


  382. VENLET J, Piers SR, Jongbloed JD, Androulakis AF, et al
    Isolated Subepicardial Right Ventricular Outflow Tract Scar in Athletes With Ventricular Tachycardia.
    J Am Coll Cardiol. 2017;69:497-507.
    PubMed     Abstract available


    January 2017
  383. VAL-BLASCO A, Piedras MJ, Ruiz-Hurtado G, Suarez N, et al
    Role of NOD1 in Heart Failure Progression via Regulation of Ca2+ Handling.
    J Am Coll Cardiol. 2017;69:423-433.
    PubMed     Abstract available


  384. SEITZ J, Bars C, Theodore G, Beurtheret S, et al
    AF Ablation Guided by Spatiotemporal Electrogram Dispersion Without Pulmonary Vein Isolation: A Wholly Patient-Tailored Approach.
    J Am Coll Cardiol. 2017;69:303-321.
    PubMed     Abstract available


  385. MADHAVAN M, Mulpuru SK, McLeod CJ, Cha YM, et al
    Advances and Future Directions in Cardiac Pacemakers: Part 2 of a 2-Part Series.
    J Am Coll Cardiol. 2017;69:211-235.
    PubMed     Abstract available


  386. MULPURU SK, Madhavan M, McLeod CJ, Cha YM, et al
    Cardiac Pacemakers: Function, Troubleshooting, and Management: Part 1 of a 2-Part Series.
    J Am Coll Cardiol. 2017;69:189-210.
    PubMed     Abstract available


    August 2016
  387. PARASHAR A, Sud K, Devgun J, Agarwal S, et al
    Feasibility of LAA Closure for Left Atrial Thrombus in Patients With Aortic Stenosis and AF.
    J Am Coll Cardiol. 2016;68:770-1.
    PubMed    


    May 2016
  388. SINNECKER D, Dommasch M, Steger A, Berkefeld A, et al
    Expiration-Triggered Sinus Arrhythmia Predicts Outcome in Survivors of Acute Myocardial Infarction.
    J Am Coll Cardiol. 2016;67:2213-20.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: